SlideShare a Scribd company logo
1 of 38
Download to read offline
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
Pharmaceutical Industry Trends in Australia
Tiago Antonio Ferreira da Silva
September,20th
2012 – Perth Western Australia
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
Agenda:
 Pharmaceutical Industry Profile in Australia
 About Pfizer
 Forces at work in healthcare
 Trends
 PEST
 Opportunities
 Australia Strategy
 Conclusion
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
AUD 22 BILLION
Australian Pharmaceutical Market in AUD Billion
Source: IBIS World, Pharmaceuticals
Product in Australia, 2011
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
AUD 30.5
BILLION
Australian Pharmaceutical Market in AUD Billion
Source: IBIS World, Pharmaceuticals
Product in Australia, 2011
2020 Forecast
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
Australian Pharmaceutical Industry Profile
• Australian pharmaceutical industry is ranked 15th
largest in the world.
• Revenue AUD 22 Billion.
• 1% of the global market
• $1.02 billion on R&D
• Australia’s largest exporter:Aud 4.1Billion.(over 60 countries)
• Pharmaceutical Industry employs 44.000 people.
• Continuous growth: 2.3%
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
Global Context
• Worldwide industry sales are projected to grow strongly at 7.5 per cent per
annum over the next five years.
• Project it will reach US$1,158.5 billion in 2014. The markets driving this
change will be:
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
Nobel
Australia is a leading country in
Research and Development
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
Australia proud history of seven Nobel winners in medicine
• Howard Florey (1945: development of penicillin).
• Frank Macfarlane Burnet (1960: research on organ transplantation).
• John Eccles (1963: research on the transmission of nerve impulses)
• Peter Doherty (1996: discoveries concerning the specificity of the cell
mediated immune defence)
• Barry Marshall and J. Robin Warren (2005: discovery of the bacterium
Helicobacter pylori and its role in gastritis and peptic ulcer disease).
• Elizabeth Blackburn (2009: research on telomeres, structures at the end of
chromosomes that protect the chromosome).
Source: IBIS World, Pharmaceuticals Product
Manufacturing in Australia, 2011
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
The Australian model
Companies and service related segments
including wholesaling and distribution.
Comprises bio-medical research
Biotechnology firms
Originator and generic medicines
Source: IBIS World, Pharmaceuticals Product
Manufacturing in Australia, 2011
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
The Business
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
Pfizer Mission, Vision and Value
“Working together for a healthier World”
Our mission is to apply science and our global resources
to improve health and well-being at every stage of life.
Vision:
Mission:
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
About Pfizer
• Pfizer was founded in 1849 in New York by a German called Charles Pfizer.
• Pfizer has been operating in Australia since 21 May1956.
• Employs more than 2,000 people across Australia.
• Pfizer has three manufacturing plants based in West Ryde, NSW; Parkville, Victoria;
and Perth, Western Australia.
• Three plants export a value of $100 million.
• More than two million Australians take a Pfizer medicine in any given year .
• Nyse:24.07 US dollar
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
Pfizer price per Action source:Bloomberg,2012
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
Pfizer Australia : “ Three manufacturing plants”
These 3 plants export a value of 100 million AUD
Victoria
West Ride, Sydney
Perth
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
Pfizer R&D Activity
• Developing a new drug is expensive.
• Current estimates of the full cost of bringing a new chemical or biological
entity to market are around US$1.3 billion.
Source: IBIS World, Pharmaceuticals Product
Manufacturing in Australia, 2011
Solution…
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
Pfizer Partnership
• The National Health and Medical Research Council (NHMRC)
• Specialised research institutes, eg. Baker, Garvan, Queensland Institute of
Medical Research
• Universities
• The Commonwealth Scientific and Industrial Research Organisation (CSIRO)
• Hospitals
• Cooperative Research Centres (CRCs).
Source: IBIS World, Pharmaceuticals Product
Manufacturing in Australia, 2011
Entities supported by Australian Government
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
The Forces at work in Healthcare today
Profound Advances in
Science and Technology Aging Society in
developed word
Information
explosion & New
Media
Healthcare
plans
consolidated
Consumerism
Affordability
Transparency
of cost and
Quality
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
The Forces at work in Healthcare today
Profound Advances in
Science and Technology Aging Society in
developed word
Information
explosion & New
Media
Healthcare
plans
consolidated
Consumerism
Affordability
Transparence
of cost and
Quality
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
Trend 1 Economic: Pharmaceutical Exports from Australia
Source: ABS Cat no 53.68, International Trade
in Goods and Services Australia
Strong AUD impacts on Exportation
Competitive taxation arrangements that provide
incentives for companies to invest in relatively high
risk activities like R&D and complex, value adding
pharmaceutical manufacturing.
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
Trend 2 Social and cultural :Pharmaceutical Industry Turnover in Australia
Source: IBIS World, Pharmaceuticals Product
Manufacturing in Australia, 2011
Increase of medicines consumption
Higher life expectative.
Expanding access to its medicines and vaccines.
Creating new therapies
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
Trend 3 Economic and Technology: Employment
Source: IBIS World, Pharmaceuticals Product
Manufacturing in Australia, 2011
High salaries : more machine less workers
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
Trend 4 Political and Economical Suppliers by PBS scheme
Source: IBIS World, Pharmaceuticals Product
Manufacturing in Australia, 2011
•Government –subsidised prescription medicines
through the Pharmaceutical benefit Scheme ( PBS )
Generics growth
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
Awareness Increasing for heath care.
Source: abs,2012
3.6
4
Trend 5 : Social and Cultural
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
PEST ANALYSIS
•Large Pipeline of
Pharmaceutical companies
•New and excellent drugs
•Awareness Increasing for
heath care.
•Higher life expectative.
•Education programs
•Government –subsidized
prescription medicines
through the Pharmaceutical
benefit Scheme ( PBS )
•Annual review and addition
of expensive innovative
drugs to the PBS drug list.
•Amount of sponsorship
money or reimbursement
given to individual doctors
and research
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
PEST ANALYSIS
•Over prescritiption by
physician : “ no need”
•Best drug available for
treatments.
•Government –subsidized
prescription medicines
through the Pharmaceutical
benefit Scheme ( PBS )
•Annual review and addition
of expensive innovative
drugs to the PBS drug list.
•Amount of sponsorship
money or reimbursement
given to individual doctors
and research
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
PEST ANALYSIS
•Over prescritiption by
physician : “ no need”
•Best drug available for
treatments.
•Government –subsidised
prescription medicines
through the Pharmaceutical
benefit Scheme ( PBS )
•Annual review and addition
of expensive innovative
drugs to the PBS drug list.
•Amount of sponsorship
money or reimbursement
given to individual doctors
and research
Action to combat:
Predictable, timely and transparent
regulatory and reimbursement systems
that provide companies with a clear and
streamlined path to market.
______________________________
Follow the Compliance Code of
Conducts.
Committed to the highest standards of
ethics and integrity
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
PEST ANALYSIS
•Low quality medicines
•Impact on the medicines
prices.
•More expensive
•Strong AUD
•High expenditure on R&D.
•Generic growth
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
PEST ANALYSIS
•Low quality medicines
•Impact on the medicines
prices.
•More expensive
•Strong AUD
•High expenditure on R&D.
•Generic growth
Action to combat:
Competitive taxation arrangements that
provide incentives for companies to
invest in relatively high risk activities like
R&D and complex, value adding
pharmaceutical manufacturing.
______________________________
Expanding access to its medicines and
vaccines.
Defending the brand adding value to
the customers with a Loyalty card and
discounts.
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
PEST ANALYSIS
•Prevention of diseases.
Increase of medicines
consumption.
•Awareness Increasing for
heath care.
•Higher life expectative.
•Education programs
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
PEST ANALYSIS
•Prevention of diseases.
Increase of medicines
consumption.
•Awareness Increasing for
heath care.
•Higher life expectative.
•Education programs
Action to combat:
Strong and effective collaboration
between industry and research.
_________________________
Creating new therapies
Continued pipeline advancement
including several product launches
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
PEST ANALYSIS
•Prevention of diseases.
Fast cure
• 7 Nobel award in
researching and developing.
•More information available in
the internet.
•New potent pharmaceutical
drugs in the market.:
Biotechnological
•Education programs
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
PEST ANALYSIS
•Prevention of diseases.
Fast cure
• 7 Nobel award in
researching and developing.
•More information available in
the internet.
•New potent pharmaceutical
drugs in the market:
Biotechnological
•Education programs
Broad and Deep Commercial
Technologies
Focus on manufacturing process and
technology
Continued pipeline advancement
including several product launches
Improving the interface between
customer and Pfizer through the
internet : new programs, classes,
webcasting, chats and others.
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
Positive trends
• Easy access to pharmaceutical drugs.
• Increasing awareness of the need for the for the early detection of lifestyle
and chronic diseases.
• Government –subsidised prescription medicines through the Pharmaceutical
benefit Scheme ( PBS ) for all eligible.
• Annual review and addition of expensive innovative drugs to the PBS drug
list.
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
Focus on Opportunitties
Innovative Medicines
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
Australia Strategy
ACTIONS
POL
SOC
SOC
TEC
ECO
Focus on manufacturing process and technology
Strong and effective collaboration between
industry and research.
Broad and Deep Commercial Technologies
Competitive taxation arrangements that provide
incentives for companies to invest in relatively high
risk activities like R&D and complex, value adding
pharmaceutical manufacturing;
Predictable, timely and transparent regulatory
and reimbursement systems that provide
companies with a clear and streamlined path to
market.
Continued pipeline advancement including
several product launches
POL
SOC
SOC
ECO
TEC
POL
SOC
SOC
ECO
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
Conclusion
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
Reference:
• Australian Bureau Statistics,Pharmaceutical Industry, retrieved on
September 31 on: www.abs.com.au
• Bloomberg, Pfizer price per action,retrieved on September 31 on
www.bloomber.com
• Pfizer Inc,Vision Statement,retrieved on September 12,2012 on:
www.pfizer.com
Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt
Thanks

More Related Content

More from Ts Agency

Coach 9 plano de acao
Coach 9   plano de acaoCoach 9   plano de acao
Coach 9 plano de acaoTs Agency
 
Coach 8 por que enterrar o passado
Coach 8  por que enterrar o passadoCoach 8  por que enterrar o passado
Coach 8 por que enterrar o passadoTs Agency
 
Coach 7 revisando a bagagem de mao
Coach 7   revisando a bagagem de maoCoach 7   revisando a bagagem de mao
Coach 7 revisando a bagagem de maoTs Agency
 
Coach 6 a clareza do proposito
Coach 6   a clareza do propositoCoach 6   a clareza do proposito
Coach 6 a clareza do propositoTs Agency
 
Coach 5 a linguagem do projeto e a linguagem do
Coach 5  a linguagem do projeto e a linguagem doCoach 5  a linguagem do projeto e a linguagem do
Coach 5 a linguagem do projeto e a linguagem doTs Agency
 
Coach 4 interpretacao deo conceito de feedback
Coach 4   interpretacao deo conceito de feedbackCoach 4   interpretacao deo conceito de feedback
Coach 4 interpretacao deo conceito de feedbackTs Agency
 
Coach 3 uma relacao de confianca abertura e responsabilidade
Coach 3  uma relacao de confianca abertura e responsabilidadeCoach 3  uma relacao de confianca abertura e responsabilidade
Coach 3 uma relacao de confianca abertura e responsabilidadeTs Agency
 
Coach 2 um exercicio refinado de lideranca
Coach 2   um exercicio refinado de liderancaCoach 2   um exercicio refinado de lideranca
Coach 2 um exercicio refinado de liderancaTs Agency
 
Coach 1 uma ponte entre o sonho e a realizacao
Coach 1   uma ponte entre o sonho e a realizacaoCoach 1   uma ponte entre o sonho e a realizacao
Coach 1 uma ponte entre o sonho e a realizacaoTs Agency
 
As 7 leis espirituais do sucesso
As 7 leis espirituais do sucessoAs 7 leis espirituais do sucesso
As 7 leis espirituais do sucessoTs Agency
 
Processo interativo de vendas 2
Processo interativo de vendas 2Processo interativo de vendas 2
Processo interativo de vendas 2Ts Agency
 
TCC Choperia Genuíno : ESPM Curso de Pós Graduação em Pesquisa de Mercado, O...
TCC  Choperia Genuíno : ESPM Curso de Pós Graduação em Pesquisa de Mercado, O...TCC  Choperia Genuíno : ESPM Curso de Pós Graduação em Pesquisa de Mercado, O...
TCC Choperia Genuíno : ESPM Curso de Pós Graduação em Pesquisa de Mercado, O...Ts Agency
 
Felicidade e a prosperidade na maçonaria
Felicidade e a prosperidade na maçonariaFelicidade e a prosperidade na maçonaria
Felicidade e a prosperidade na maçonariaTs Agency
 
Emotion marketing
Emotion marketingEmotion marketing
Emotion marketingTs Agency
 
TCC - Business School São Paulo - Marketing Farmacêutico Dayprox
TCC - Business School São Paulo - Marketing Farmacêutico DayproxTCC - Business School São Paulo - Marketing Farmacêutico Dayprox
TCC - Business School São Paulo - Marketing Farmacêutico DayproxTs Agency
 
The windsor
The windsor The windsor
The windsor Ts Agency
 
Farmacovigilância 2013
Farmacovigilância 2013Farmacovigilância 2013
Farmacovigilância 2013Ts Agency
 
Little creatures in japan
Little creatures in japanLittle creatures in japan
Little creatures in japanTs Agency
 
Avodart campinas[1]
Avodart campinas[1]Avodart campinas[1]
Avodart campinas[1]Ts Agency
 

More from Ts Agency (20)

Coach 9 plano de acao
Coach 9   plano de acaoCoach 9   plano de acao
Coach 9 plano de acao
 
Coach 8 por que enterrar o passado
Coach 8  por que enterrar o passadoCoach 8  por que enterrar o passado
Coach 8 por que enterrar o passado
 
Coach 7 revisando a bagagem de mao
Coach 7   revisando a bagagem de maoCoach 7   revisando a bagagem de mao
Coach 7 revisando a bagagem de mao
 
Coach 6 a clareza do proposito
Coach 6   a clareza do propositoCoach 6   a clareza do proposito
Coach 6 a clareza do proposito
 
Coach 5 a linguagem do projeto e a linguagem do
Coach 5  a linguagem do projeto e a linguagem doCoach 5  a linguagem do projeto e a linguagem do
Coach 5 a linguagem do projeto e a linguagem do
 
Coach 4 interpretacao deo conceito de feedback
Coach 4   interpretacao deo conceito de feedbackCoach 4   interpretacao deo conceito de feedback
Coach 4 interpretacao deo conceito de feedback
 
Coach 3 uma relacao de confianca abertura e responsabilidade
Coach 3  uma relacao de confianca abertura e responsabilidadeCoach 3  uma relacao de confianca abertura e responsabilidade
Coach 3 uma relacao de confianca abertura e responsabilidade
 
Coach 2 um exercicio refinado de lideranca
Coach 2   um exercicio refinado de liderancaCoach 2   um exercicio refinado de lideranca
Coach 2 um exercicio refinado de lideranca
 
Coach 1 uma ponte entre o sonho e a realizacao
Coach 1   uma ponte entre o sonho e a realizacaoCoach 1   uma ponte entre o sonho e a realizacao
Coach 1 uma ponte entre o sonho e a realizacao
 
As 7 leis espirituais do sucesso
As 7 leis espirituais do sucessoAs 7 leis espirituais do sucesso
As 7 leis espirituais do sucesso
 
Processo interativo de vendas 2
Processo interativo de vendas 2Processo interativo de vendas 2
Processo interativo de vendas 2
 
TCC Choperia Genuíno : ESPM Curso de Pós Graduação em Pesquisa de Mercado, O...
TCC  Choperia Genuíno : ESPM Curso de Pós Graduação em Pesquisa de Mercado, O...TCC  Choperia Genuíno : ESPM Curso de Pós Graduação em Pesquisa de Mercado, O...
TCC Choperia Genuíno : ESPM Curso de Pós Graduação em Pesquisa de Mercado, O...
 
Felicidade e a prosperidade na maçonaria
Felicidade e a prosperidade na maçonariaFelicidade e a prosperidade na maçonaria
Felicidade e a prosperidade na maçonaria
 
Emotion marketing
Emotion marketingEmotion marketing
Emotion marketing
 
Emirates
Emirates Emirates
Emirates
 
TCC - Business School São Paulo - Marketing Farmacêutico Dayprox
TCC - Business School São Paulo - Marketing Farmacêutico DayproxTCC - Business School São Paulo - Marketing Farmacêutico Dayprox
TCC - Business School São Paulo - Marketing Farmacêutico Dayprox
 
The windsor
The windsor The windsor
The windsor
 
Farmacovigilância 2013
Farmacovigilância 2013Farmacovigilância 2013
Farmacovigilância 2013
 
Little creatures in japan
Little creatures in japanLittle creatures in japan
Little creatures in japan
 
Avodart campinas[1]
Avodart campinas[1]Avodart campinas[1]
Avodart campinas[1]
 

Recently uploaded

Anyhr.io | Presentation HR&Recruiting agency
Anyhr.io | Presentation HR&Recruiting agencyAnyhr.io | Presentation HR&Recruiting agency
Anyhr.io | Presentation HR&Recruiting agencyHanna Klim
 
Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024Borderless Access
 
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John Meulemans
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John MeulemansBCE24 | Virtual Brand Ambassadors: Making Brands Personal - John Meulemans
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John MeulemansBBPMedia1
 
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdf
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdfGraham and Doddsville - Issue 1 - Winter 2006 (1).pdf
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdfAnhNguyen97152
 
Mihir Menda - Member of Supervisory Board at RMZ
Mihir Menda - Member of Supervisory Board at RMZMihir Menda - Member of Supervisory Board at RMZ
Mihir Menda - Member of Supervisory Board at RMZKanakChauhan5
 
Lecture_6.pptx English speaking easyb to
Lecture_6.pptx English speaking easyb toLecture_6.pptx English speaking easyb to
Lecture_6.pptx English speaking easyb toumarfarooquejamali32
 
NewBase 25 March 2024 Energy News issue - 1710 by Khaled Al Awadi_compress...
NewBase  25 March  2024  Energy News issue - 1710 by Khaled Al Awadi_compress...NewBase  25 March  2024  Energy News issue - 1710 by Khaled Al Awadi_compress...
NewBase 25 March 2024 Energy News issue - 1710 by Khaled Al Awadi_compress...Khaled Al Awadi
 
Entrepreneurship & organisations: influences and organizations
Entrepreneurship & organisations: influences and organizationsEntrepreneurship & organisations: influences and organizations
Entrepreneurship & organisations: influences and organizationsP&CO
 
To Create Your Own Wig Online To Create Your Own Wig Online
To Create Your Own Wig Online  To Create Your Own Wig OnlineTo Create Your Own Wig Online  To Create Your Own Wig Online
To Create Your Own Wig Online To Create Your Own Wig Onlinelng ths
 
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for BusinessQ2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for BusinessAPCO
 
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdf
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdfChicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdf
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdfSourav Sikder
 
AMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdf
AMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdfAMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdf
AMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdfJohnCarloValencia4
 
Building Your Personal Brand on LinkedIn - Expert Planet- 2024
 Building Your Personal Brand on LinkedIn - Expert Planet-  2024 Building Your Personal Brand on LinkedIn - Expert Planet-  2024
Building Your Personal Brand on LinkedIn - Expert Planet- 2024Stephan Koning
 
Data skills for Agile Teams- Killing story points
Data skills for Agile Teams- Killing story pointsData skills for Agile Teams- Killing story points
Data skills for Agile Teams- Killing story pointsyasinnathani
 
Michael Vidyakin: Introduction to PMO (UA)
Michael Vidyakin: Introduction to PMO (UA)Michael Vidyakin: Introduction to PMO (UA)
Michael Vidyakin: Introduction to PMO (UA)Lviv Startup Club
 
Plano de marketing- inglês em formato ppt
Plano de marketing- inglês  em formato pptPlano de marketing- inglês  em formato ppt
Plano de marketing- inglês em formato pptElizangelaSoaresdaCo
 
Intellectual Property Licensing Examples
Intellectual Property Licensing ExamplesIntellectual Property Licensing Examples
Intellectual Property Licensing Examplesamberjiles31
 
Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...
Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...
Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...IMARC Group
 
MoneyBridge Pitch Deck - Investor Presentation
MoneyBridge Pitch Deck - Investor PresentationMoneyBridge Pitch Deck - Investor Presentation
MoneyBridge Pitch Deck - Investor Presentationbaron83
 

Recently uploaded (20)

Anyhr.io | Presentation HR&Recruiting agency
Anyhr.io | Presentation HR&Recruiting agencyAnyhr.io | Presentation HR&Recruiting agency
Anyhr.io | Presentation HR&Recruiting agency
 
Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024
 
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John Meulemans
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John MeulemansBCE24 | Virtual Brand Ambassadors: Making Brands Personal - John Meulemans
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John Meulemans
 
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdf
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdfGraham and Doddsville - Issue 1 - Winter 2006 (1).pdf
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdf
 
WAM Corporate Presentation Mar 25 2024.pdf
WAM Corporate Presentation Mar 25 2024.pdfWAM Corporate Presentation Mar 25 2024.pdf
WAM Corporate Presentation Mar 25 2024.pdf
 
Mihir Menda - Member of Supervisory Board at RMZ
Mihir Menda - Member of Supervisory Board at RMZMihir Menda - Member of Supervisory Board at RMZ
Mihir Menda - Member of Supervisory Board at RMZ
 
Lecture_6.pptx English speaking easyb to
Lecture_6.pptx English speaking easyb toLecture_6.pptx English speaking easyb to
Lecture_6.pptx English speaking easyb to
 
NewBase 25 March 2024 Energy News issue - 1710 by Khaled Al Awadi_compress...
NewBase  25 March  2024  Energy News issue - 1710 by Khaled Al Awadi_compress...NewBase  25 March  2024  Energy News issue - 1710 by Khaled Al Awadi_compress...
NewBase 25 March 2024 Energy News issue - 1710 by Khaled Al Awadi_compress...
 
Entrepreneurship & organisations: influences and organizations
Entrepreneurship & organisations: influences and organizationsEntrepreneurship & organisations: influences and organizations
Entrepreneurship & organisations: influences and organizations
 
To Create Your Own Wig Online To Create Your Own Wig Online
To Create Your Own Wig Online  To Create Your Own Wig OnlineTo Create Your Own Wig Online  To Create Your Own Wig Online
To Create Your Own Wig Online To Create Your Own Wig Online
 
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for BusinessQ2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
 
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdf
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdfChicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdf
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdf
 
AMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdf
AMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdfAMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdf
AMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdf
 
Building Your Personal Brand on LinkedIn - Expert Planet- 2024
 Building Your Personal Brand on LinkedIn - Expert Planet-  2024 Building Your Personal Brand on LinkedIn - Expert Planet-  2024
Building Your Personal Brand on LinkedIn - Expert Planet- 2024
 
Data skills for Agile Teams- Killing story points
Data skills for Agile Teams- Killing story pointsData skills for Agile Teams- Killing story points
Data skills for Agile Teams- Killing story points
 
Michael Vidyakin: Introduction to PMO (UA)
Michael Vidyakin: Introduction to PMO (UA)Michael Vidyakin: Introduction to PMO (UA)
Michael Vidyakin: Introduction to PMO (UA)
 
Plano de marketing- inglês em formato ppt
Plano de marketing- inglês  em formato pptPlano de marketing- inglês  em formato ppt
Plano de marketing- inglês em formato ppt
 
Intellectual Property Licensing Examples
Intellectual Property Licensing ExamplesIntellectual Property Licensing Examples
Intellectual Property Licensing Examples
 
Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...
Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...
Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...
 
MoneyBridge Pitch Deck - Investor Presentation
MoneyBridge Pitch Deck - Investor PresentationMoneyBridge Pitch Deck - Investor Presentation
MoneyBridge Pitch Deck - Investor Presentation
 

Pharma trends Australia 2012

  • 1. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt Pharmaceutical Industry Trends in Australia Tiago Antonio Ferreira da Silva September,20th 2012 – Perth Western Australia
  • 2. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt Agenda:  Pharmaceutical Industry Profile in Australia  About Pfizer  Forces at work in healthcare  Trends  PEST  Opportunities  Australia Strategy  Conclusion
  • 3. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt AUD 22 BILLION Australian Pharmaceutical Market in AUD Billion Source: IBIS World, Pharmaceuticals Product in Australia, 2011
  • 4. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt AUD 30.5 BILLION Australian Pharmaceutical Market in AUD Billion Source: IBIS World, Pharmaceuticals Product in Australia, 2011 2020 Forecast
  • 5. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt Australian Pharmaceutical Industry Profile • Australian pharmaceutical industry is ranked 15th largest in the world. • Revenue AUD 22 Billion. • 1% of the global market • $1.02 billion on R&D • Australia’s largest exporter:Aud 4.1Billion.(over 60 countries) • Pharmaceutical Industry employs 44.000 people. • Continuous growth: 2.3%
  • 6. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt Global Context • Worldwide industry sales are projected to grow strongly at 7.5 per cent per annum over the next five years. • Project it will reach US$1,158.5 billion in 2014. The markets driving this change will be:
  • 7. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt Nobel Australia is a leading country in Research and Development
  • 8. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt Australia proud history of seven Nobel winners in medicine • Howard Florey (1945: development of penicillin). • Frank Macfarlane Burnet (1960: research on organ transplantation). • John Eccles (1963: research on the transmission of nerve impulses) • Peter Doherty (1996: discoveries concerning the specificity of the cell mediated immune defence) • Barry Marshall and J. Robin Warren (2005: discovery of the bacterium Helicobacter pylori and its role in gastritis and peptic ulcer disease). • Elizabeth Blackburn (2009: research on telomeres, structures at the end of chromosomes that protect the chromosome). Source: IBIS World, Pharmaceuticals Product Manufacturing in Australia, 2011
  • 9. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt The Australian model Companies and service related segments including wholesaling and distribution. Comprises bio-medical research Biotechnology firms Originator and generic medicines Source: IBIS World, Pharmaceuticals Product Manufacturing in Australia, 2011
  • 10. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt The Business
  • 11. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt Pfizer Mission, Vision and Value “Working together for a healthier World” Our mission is to apply science and our global resources to improve health and well-being at every stage of life. Vision: Mission:
  • 12. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt About Pfizer • Pfizer was founded in 1849 in New York by a German called Charles Pfizer. • Pfizer has been operating in Australia since 21 May1956. • Employs more than 2,000 people across Australia. • Pfizer has three manufacturing plants based in West Ryde, NSW; Parkville, Victoria; and Perth, Western Australia. • Three plants export a value of $100 million. • More than two million Australians take a Pfizer medicine in any given year . • Nyse:24.07 US dollar
  • 13. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt Pfizer price per Action source:Bloomberg,2012
  • 14. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt Pfizer Australia : “ Three manufacturing plants” These 3 plants export a value of 100 million AUD Victoria West Ride, Sydney Perth
  • 15. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt Pfizer R&D Activity • Developing a new drug is expensive. • Current estimates of the full cost of bringing a new chemical or biological entity to market are around US$1.3 billion. Source: IBIS World, Pharmaceuticals Product Manufacturing in Australia, 2011 Solution…
  • 16. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt Pfizer Partnership • The National Health and Medical Research Council (NHMRC) • Specialised research institutes, eg. Baker, Garvan, Queensland Institute of Medical Research • Universities • The Commonwealth Scientific and Industrial Research Organisation (CSIRO) • Hospitals • Cooperative Research Centres (CRCs). Source: IBIS World, Pharmaceuticals Product Manufacturing in Australia, 2011 Entities supported by Australian Government
  • 17. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt The Forces at work in Healthcare today Profound Advances in Science and Technology Aging Society in developed word Information explosion & New Media Healthcare plans consolidated Consumerism Affordability Transparency of cost and Quality
  • 18. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt The Forces at work in Healthcare today Profound Advances in Science and Technology Aging Society in developed word Information explosion & New Media Healthcare plans consolidated Consumerism Affordability Transparence of cost and Quality
  • 19. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt Trend 1 Economic: Pharmaceutical Exports from Australia Source: ABS Cat no 53.68, International Trade in Goods and Services Australia Strong AUD impacts on Exportation Competitive taxation arrangements that provide incentives for companies to invest in relatively high risk activities like R&D and complex, value adding pharmaceutical manufacturing.
  • 20. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt Trend 2 Social and cultural :Pharmaceutical Industry Turnover in Australia Source: IBIS World, Pharmaceuticals Product Manufacturing in Australia, 2011 Increase of medicines consumption Higher life expectative. Expanding access to its medicines and vaccines. Creating new therapies
  • 21. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt Trend 3 Economic and Technology: Employment Source: IBIS World, Pharmaceuticals Product Manufacturing in Australia, 2011 High salaries : more machine less workers
  • 22. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt Trend 4 Political and Economical Suppliers by PBS scheme Source: IBIS World, Pharmaceuticals Product Manufacturing in Australia, 2011 •Government –subsidised prescription medicines through the Pharmaceutical benefit Scheme ( PBS ) Generics growth
  • 23. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt Awareness Increasing for heath care. Source: abs,2012 3.6 4 Trend 5 : Social and Cultural
  • 24. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt PEST ANALYSIS •Large Pipeline of Pharmaceutical companies •New and excellent drugs •Awareness Increasing for heath care. •Higher life expectative. •Education programs •Government –subsidized prescription medicines through the Pharmaceutical benefit Scheme ( PBS ) •Annual review and addition of expensive innovative drugs to the PBS drug list. •Amount of sponsorship money or reimbursement given to individual doctors and research
  • 25. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt PEST ANALYSIS •Over prescritiption by physician : “ no need” •Best drug available for treatments. •Government –subsidized prescription medicines through the Pharmaceutical benefit Scheme ( PBS ) •Annual review and addition of expensive innovative drugs to the PBS drug list. •Amount of sponsorship money or reimbursement given to individual doctors and research
  • 26. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt PEST ANALYSIS •Over prescritiption by physician : “ no need” •Best drug available for treatments. •Government –subsidised prescription medicines through the Pharmaceutical benefit Scheme ( PBS ) •Annual review and addition of expensive innovative drugs to the PBS drug list. •Amount of sponsorship money or reimbursement given to individual doctors and research Action to combat: Predictable, timely and transparent regulatory and reimbursement systems that provide companies with a clear and streamlined path to market. ______________________________ Follow the Compliance Code of Conducts. Committed to the highest standards of ethics and integrity
  • 27. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt PEST ANALYSIS •Low quality medicines •Impact on the medicines prices. •More expensive •Strong AUD •High expenditure on R&D. •Generic growth
  • 28. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt PEST ANALYSIS •Low quality medicines •Impact on the medicines prices. •More expensive •Strong AUD •High expenditure on R&D. •Generic growth Action to combat: Competitive taxation arrangements that provide incentives for companies to invest in relatively high risk activities like R&D and complex, value adding pharmaceutical manufacturing. ______________________________ Expanding access to its medicines and vaccines. Defending the brand adding value to the customers with a Loyalty card and discounts.
  • 29. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt PEST ANALYSIS •Prevention of diseases. Increase of medicines consumption. •Awareness Increasing for heath care. •Higher life expectative. •Education programs
  • 30. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt PEST ANALYSIS •Prevention of diseases. Increase of medicines consumption. •Awareness Increasing for heath care. •Higher life expectative. •Education programs Action to combat: Strong and effective collaboration between industry and research. _________________________ Creating new therapies Continued pipeline advancement including several product launches
  • 31. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt PEST ANALYSIS •Prevention of diseases. Fast cure • 7 Nobel award in researching and developing. •More information available in the internet. •New potent pharmaceutical drugs in the market.: Biotechnological •Education programs
  • 32. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt PEST ANALYSIS •Prevention of diseases. Fast cure • 7 Nobel award in researching and developing. •More information available in the internet. •New potent pharmaceutical drugs in the market: Biotechnological •Education programs Broad and Deep Commercial Technologies Focus on manufacturing process and technology Continued pipeline advancement including several product launches Improving the interface between customer and Pfizer through the internet : new programs, classes, webcasting, chats and others.
  • 33. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt Positive trends • Easy access to pharmaceutical drugs. • Increasing awareness of the need for the for the early detection of lifestyle and chronic diseases. • Government –subsidised prescription medicines through the Pharmaceutical benefit Scheme ( PBS ) for all eligible. • Annual review and addition of expensive innovative drugs to the PBS drug list.
  • 34. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt Focus on Opportunitties Innovative Medicines
  • 35. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt Australia Strategy ACTIONS POL SOC SOC TEC ECO Focus on manufacturing process and technology Strong and effective collaboration between industry and research. Broad and Deep Commercial Technologies Competitive taxation arrangements that provide incentives for companies to invest in relatively high risk activities like R&D and complex, value adding pharmaceutical manufacturing; Predictable, timely and transparent regulatory and reimbursement systems that provide companies with a clear and streamlined path to market. Continued pipeline advancement including several product launches POL SOC SOC ECO TEC POL SOC SOC ECO
  • 36. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt Conclusion
  • 37. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt Reference: • Australian Bureau Statistics,Pharmaceutical Industry, retrieved on September 31 on: www.abs.com.au • Bloomberg, Pfizer price per action,retrieved on September 31 on www.bloomber.com • Pfizer Inc,Vision Statement,retrieved on September 12,2012 on: www.pfizer.com
  • 38. Central Institute of Technology Diploma of Marketing: Tiago Antonio Ferreira da Silva Lecture: Rebel Carratt Thanks